Browsing Tag
EQT
41 posts
EQT offers €46.50 for QIAGEN in $10.8bn deal, but which takeover premium matters?
EQT has agreed a €46.50-per-share cash takeover of QIAGEN, valuing the molecular diagnostics group at about €9.6 billion, but the deal’s apparently conflicting takeover premiums reveal how months of acquisition speculation had already moved the stock.
America is moving away from synthetic food dyes. Why could Oterra be one of the biggest beneficiaries?
Oterra has installed former Royal Greenland chief Susanne Arfelt Rajamand as Chief Executive Officer as United States food companies accelerate their move away from synthetic dyes. The privately owned ingredients group says its core US business could double within two years, giving its new leader an unusually clear growth opportunity but also a major manufacturing and supply-chain execution challenge.
Waystar explores potential sale as healthcare software valuation gap draws buyer interest
Waystar is exploring a potential sale as strong margins and recurring revenue clash with a stock price still well below its 52-week high.
EUCLYD secures over €200m as Europe searches for an answer to AI inference costs
Eindhoven-based EUCLYD has secured more than €200 million in Series A financing from investors including Samsung and an EQT-managed fund, while former ASML chief Peter Wennink joins as chairman as the startup tries to commercialise a new architecture for AI inference.
Lovable is now worth $13.3bn, but its biggest test starts after the app is built
Swedish AI software company Lovable has doubled its valuation to $13.3 billion just eight months after its previous funding round. The $400 million Series C gives Lovable more capital to turn AI-assisted app creation into a broader platform for running businesses, but the valuation increasingly depends on revenue quality, infrastructure economics and enterprise adoption rather than headline project creation.
Cleanaway gets A$9.4bn EQT proposal as A$3.13 offer puts 20x EBIT valuation on ASX: CWY
Cleanaway’s A$9.4bn EQT proposal offers A$3.13 a share, but due diligence, approvals and a 20x EBIT valuation still separate the bid from a final deal.
South Korea’s Lotte sells car rental unit to TPG for $925m
TPG's 1.31 trillion won Lotte Rental deal hands Lotte Group liquidity at a discount to the collapsed Affinity bid, with KFTC review still the last hurdle.
Oxford Biomedica (LSE: OXB) plunges 15% as 2026 revenue guidance falls
Oxford Biomedica cut 2026 revenue guidance by £40m at midpoint. September results must show whether OXB’s setback is timing or something deeper.
Zayo and NVIDIA target AI network bottleneck with six new long-haul fibre routes
Zayo is working with NVIDIA to expand long-haul fibre capacity across emerging United States AI corridors, linking the semiconductor company’s accelerated-computing ecosystem with Zayo’s largest network construction programme. The infrastructure opportunity is substantial, but undisclosed commercial terms and long construction cycles leave the financial returns dependent on customer commitments, utilisation and disciplined execution.
IFS H1 2026 growth puts industrial AI scale, customer expansion and IPO readiness under scrutiny
IFS is scaling industrial AI across critical operations, but durable margins, acquisition integration and eventual IPO readiness remain the next tests.